2025-2031 Global Cytotoxicity Testing Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Medical Care > 2025-2031 Global Cytotoxicity Testing Industry Research & Trends Analysis Report

2025-2031 Global Cytotoxicity Testing Industry Research & Trends Analysis Report

Publication Date: 2025-12-12
Report Id: 2862903
Industry: Medical Care
Report Page: 139
Chart: 142

PDF Download

Publication Date: 2025-12-12
Report Id: 2862903
Industry: Medical Care
Report Page: 139
Chart: 142

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Product Overview and Scope of Cytotoxicity Testing
1.2 Global Cytotoxicity Testing Market Size and Forecast
1.3 China Cytotoxicity Testing Market Size and Forecast
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Cytotoxicity Testing Share in Global Market, 2020-2031
1.4.2 Cytotoxicity Testing Market Size: China VS Global, 2020-2031
1.5 Cytotoxicity Testing Market Dynamics
1.5.1 Cytotoxicity Testing Market Drivers
1.5.2 Cytotoxicity Testing Market Restraints
1.5.3 Cytotoxicity Testing Industry Trends
1.5.4 Cytotoxicity Testing Industry Policy

2 Competitive Landscape by Company
2.1 Global Cytotoxicity Testing Revenue by Company, 2020-2025
2.2 Global Cytotoxicity Testing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Cytotoxicity Testing Concentration Ratio
2.4 Global Cytotoxicity Testing Mergers & Acquisitions, Expansion Plans
2.5 Global Cytotoxicity Testing Manufacturers Product Type
2.6 Global Geographic Distribution of Cytotoxicity Testing Companies

3 China Competitive Situation by Company
3.1 China Cytotoxicity Testing Revenue by Company, 2020-2025
3.2 China Cytotoxicity Testing Cytotoxicity Testing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.3 China Cytotoxicity Testing Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)

4 Industry Chain Analysis
4.1 Cytotoxicity Testing Industry Chain
4.2 Cytotoxicity Testing Upstream Analysis
4.3 Cytotoxicity Testing Midstream Analysis
4.4 Cytotoxicity Testing Downstream Analysis

5 Sights by Type
5.1 Cytotoxicity Testing Classification by Type
5.1.1 Elution Testing Method
5.1.2 Agar Overlay Method
5.1.3 Direct Contact Method
5.1.4 MTT Assay Method
5.1.5 Others
5.2 by Type, Global Cytotoxicity Testing Market Size & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Cytotoxicity Testing Market Size, 2020-2031

6 Sights by Cell
6.1 Cytotoxicity Testing Classification by Cell
6.1.1 Single-layer Cells
6.1.2 Three-dimensional Cells
6.1.3 Others
6.2 by Cell, Global Cytotoxicity Testing Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Cell, Global Cytotoxicity Testing Market Size, 2020-2031

7 Sights by Purpose
7.1 Cytotoxicity Testing Classification by Purpose
7.1.1 Toxicity Screening
7.1.2 Toxicity Classification
7.1.3 Toxicity Mechanism Research
7.1.4 Others
7.2 by Purpose, Global Cytotoxicity Testing Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Purpose, Global Cytotoxicity Testing Market Size, 2020-2031

8 Sights by Application
8.1 Cytotoxicity Testing Segment by Application
8.1.1 Medical Device
8.1.2 Medical Accessories
8.1.3 Others
8.2 by Application, Global Cytotoxicity Testing Market Size & CAGR, 2020 VS 2024 VS 2031
8.3 by Application, Global Cytotoxicity Testing Market Size, 2020-2031

9 Sights by Region
9.1 By Region, Global Cytotoxicity Testing Market Size, 2020 VS 2024 VS 2031
9.2 By Region, Global Cytotoxicity Testing Market Size, 2020-2031
9.3 North America
9.3.1 North America Cytotoxicity Testing Market Size & Forecasts, 2020-2031
9.3.2 By Country, North America Cytotoxicity Testing Market Size Market Share
9.4 Europe
9.4.1 Europe Cytotoxicity Testing Market Size & Forecasts, 2020-2031
9.4.2 By Country, Europe Cytotoxicity Testing Market Size Market Share
9.5 Asia Pacific
9.5.1 Asia Pacific Cytotoxicity Testing Market Size & Forecasts, 2020-2031
9.5.2 By Country/Region, Asia Pacific Cytotoxicity Testing Market Size Market Share
9.6 South America
9.6.1 South America Cytotoxicity Testing Market Size & Forecasts, 2020-2031
9.6.2 By Country, South America Cytotoxicity Testing Market Size Market Share
9.7 Middle East & Africa

10 Sights by Country Level
10.1 By Country, Global Cytotoxicity Testing Market Size & CAGR，2020 VS 2024 VS 2031
10.2 By Country, Global Cytotoxicity Testing Market Size, 2020-2031
10.3 United States
10.3.1 United States Cytotoxicity Testing Market Size, 2020-2031
10.3.2 By Company, United States Cytotoxicity Testing Revenue Market Share, 2024
10.3.3 by Type, United States Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.3.4 by Application, United States Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.4 Europe
10.4.1 Europe Cytotoxicity Testing Market Size, 2020-2031
10.4.2 By Company, Europe Cytotoxicity Testing Revenue Market Share, 2024
10.4.3 by Type, Europe Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.4.4 by Application, Europe Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.5 China
10.5.1 China Cytotoxicity Testing Market Size, 2020-2031
10.5.2 By Company, China Cytotoxicity Testing Revenue Market Share, 2024
10.5.3 by Type, China Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.5.4 by Application, China Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.6 Japan
10.6.1 Japan Cytotoxicity Testing Market Size, 2020-2031
10.6.2 By Company, Japan Cytotoxicity Testing Revenue Market Share, 2024
10.6.3 by Type, Japan Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.6.4 by Application, Japan Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.7 South Korea
10.7.1 South Korea Cytotoxicity Testing Market Size, 2020-2031
10.7.2 By Company, South Korea Cytotoxicity Testing Revenue Market Share, 2024
10.7.3 by Type, South Korea Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.7.4 by Application, South Korea Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.8 Southeast Asia
10.8.1 Southeast Asia Cytotoxicity Testing Market Size, 2020-2031
10.8.2 By Company, Southeast Asia Cytotoxicity Testing Revenue Market Share, 2024
10.8.3 by Type, Southeast Asia Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.8.4 by Application, Southeast Asia Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.9 India
10.9.1 India Cytotoxicity Testing Market Size, 2020-2031
10.9.2 By Company, India Cytotoxicity Testing Revenue Market Share, 2024
10.9.3 by Type, India Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.9.4 by Application, India Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.10 Middle East & Africa
10.10.1 Middle East & Africa Cytotoxicity Testing Market Size, 2020-2031
10.10.2 By Company, Middle East & Africa Cytotoxicity Testing Revenue Market Share, 2024
10.10.3 by Type, Middle East & Africa Cytotoxicity Testing Revenue Market Share, 2024 VS 2031
10.10.4 by Application, Middle East & Africa Cytotoxicity Testing Revenue Market Share, 2024 VS 2031

11 Company Profile
11.1 Intertek
11.1.1 Intertek Company Information, Head Office, Market Area, and Industry Position
11.1.2 Intertek Company Profile and Main Business
11.1.3 Intertek Cytotoxicity Testing Models, Specifications, and Application
11.1.4 Intertek Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.1.5 Intertek Recent Developments
11.2 UL Solutions
11.2.1 UL Solutions Company Information, Head Office, Market Area, and Industry Position
11.2.2 UL Solutions Company Profile and Main Business
11.2.3 UL Solutions Cytotoxicity Testing Models, Specifications, and Application
11.2.4 UL Solutions Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.2.5 UL Solutions Recent Developments
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Information, Head Office, Market Area, and Industry Position
11.3.2 Eurofins Scientific Company Profile and Main Business
11.3.3 Eurofins Scientific Cytotoxicity Testing Models, Specifications, and Application
11.3.4 Eurofins Scientific Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.3.5 Eurofins Scientific Recent Developments
11.4 SGS
11.4.1 SGS Company Information, Head Office, Market Area, and Industry Position
11.4.2 SGS Company Profile and Main Business
11.4.3 SGS Cytotoxicity Testing Models, Specifications, and Application
11.4.4 SGS Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.4.5 SGS Recent Developments
11.5 Creative Bioarray
11.5.1 Creative Bioarray Company Information, Head Office, Market Area, and Industry Position
11.5.2 Creative Bioarray Company Profile and Main Business
11.5.3 Creative Bioarray Cytotoxicity Testing Models, Specifications, and Application
11.5.4 Creative Bioarray Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.5.5 Creative Bioarray Recent Developments
11.6 Nelson Labs
11.6.1 Nelson Labs Company Information, Head Office, Market Area, and Industry Position
11.6.2 Nelson Labs Company Profile and Main Business
11.6.3 Nelson Labs Cytotoxicity Testing Models, Specifications, and Application
11.6.4 Nelson Labs Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.6.5 Nelson Labs Recent Developments
11.7 SBH Sciences
11.7.1 SBH Sciences Company Information, Head Office, Market Area, and Industry Position
11.7.2 SBH Sciences Company Profile and Main Business
11.7.3 SBH Sciences Cytotoxicity Testing Models, Specifications, and Application
11.7.4 SBH Sciences Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.7.5 SBH Sciences Recent Developments
11.8 Pacific BioLabs
11.8.1 Pacific BioLabs Company Information, Head Office, Market Area, and Industry Position
11.8.2 Pacific BioLabs Company Profile and Main Business
11.8.3 Pacific BioLabs Cytotoxicity Testing Models, Specifications, and Application
11.8.4 Pacific BioLabs Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.8.5 Pacific BioLabs Recent Developments
11.9 NorthEast BioLab
11.9.1 NorthEast BioLab Company Information, Head Office, Market Area, and Industry Position
11.9.2 NorthEast BioLab Company Profile and Main Business
11.9.3 NorthEast BioLab Cytotoxicity Testing Models, Specifications, and Application
11.9.4 NorthEast BioLab Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.9.5 NorthEast BioLab Recent Developments
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Company Information, Head Office, Market Area, and Industry Position
11.10.2 Charles River Laboratories Company Profile and Main Business
11.10.3 Charles River Laboratories Cytotoxicity Testing Models, Specifications, and Application
11.10.4 Charles River Laboratories Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.10.5 Charles River Laboratories Recent Developments
11.11 INDIGO Biosciences
11.11.1 INDIGO Biosciences Company Information, Head Office, Market Area, and Industry Position
11.11.2 INDIGO Biosciences Company Profile and Main Business
11.11.3 INDIGO Biosciences Cytotoxicity Testing Models, Specifications, and Application
11.11.4 INDIGO Biosciences Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.11.5 INDIGO Biosciences Recent Developments
11.12 Evercyte
11.12.1 Evercyte Company Information, Head Office, Market Area, and Industry Position
11.12.2 Evercyte Company Profile and Main Business
11.12.3 Evercyte Cytotoxicity Testing Models, Specifications, and Application
11.12.4 Evercyte Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.12.5 Evercyte Recent Developments
11.13 IONTOX
11.13.1 IONTOX Company Information, Head Office, Market Area, and Industry Position
11.13.2 IONTOX Company Profile and Main Business
11.13.3 IONTOX Cytotoxicity Testing Models, Specifications, and Application
11.13.4 IONTOX Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.13.5 IONTOX Recent Developments
11.14 Applied StemCell
11.14.1 Applied StemCell Company Information, Head Office, Market Area, and Industry Position
11.14.2 Applied StemCell Company Profile and Main Business
11.14.3 Applied StemCell Cytotoxicity Testing Models, Specifications, and Application
11.14.4 Applied StemCell Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.14.5 Applied StemCell Recent Developments
11.15 Xenometrix AG
11.15.1 Xenometrix AG Company Information, Head Office, Market Area, and Industry Position
11.15.2 Xenometrix AG Company Profile and Main Business
11.15.3 Xenometrix AG Cytotoxicity Testing Models, Specifications, and Application
11.15.4 Xenometrix AG Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.15.5 Xenometrix AG Recent Developments
11.16 TÜV SÜD
11.16.1 TÜV SÜD Company Information, Head Office, Market Area, and Industry Position
11.16.2 TÜV SÜD Company Profile and Main Business
11.16.3 TÜV SÜD Cytotoxicity Testing Models, Specifications, and Application
11.16.4 TÜV SÜD Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.16.5 TÜV SÜD Recent Developments
11.17 Medicilon
11.17.1 Medicilon Company Information, Head Office, Market Area, and Industry Position
11.17.2 Medicilon Company Profile and Main Business
11.17.3 Medicilon Cytotoxicity Testing Models, Specifications, and Application
11.17.4 Medicilon Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.17.5 Medicilon Recent Developments
11.18 Huatongwei
11.18.1 Huatongwei Company Information, Head Office, Market Area, and Industry Position
11.18.2 Huatongwei Company Profile and Main Business
11.18.3 Huatongwei Cytotoxicity Testing Models, Specifications, and Application
11.18.4 Huatongwei Cytotoxicity Testing Revenue and Gross Margin, 2020-2025
11.18.5 Huatongwei Recent Developments

12 Conclusion

13 Appendix
13.1 Research Methodology
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Market Estimation Model
13.4 Disclaimer

According to YH Research, the global market for Cytotoxicity Testing should grow from US$ 368 million in 2024 to US$ 600 million by 2031, with a CAGR of 6.9% for the period of 2025-2031.

Cytotoxicity testing is a standardized in vitro toxicological evaluation method based on the principles of cell biology and toxicology. It involves culturing target cell lines in vitro to simulate the contact process between test substances (such as medical device materials, pharmaceuticals, cosmetics, and industrial chemicals) and cells, detecting the effects of test substances on cell survival, proliferation, morphology, function, and metabolism. Its core objective is to determine whether a test substance possesses cytotoxicity, its toxicity intensity, and its mechanism of action, providing a scientific basis for assessing the biosafety, potential hazards, and clinical feasibility of test substances. It is widely used in fields such as medical device registration, new drug development, and cosmetic safety assessment.

Cytotoxicity Testing

According to YH Research, the global market for Cytotoxicity Testing should grow from US$ 368 million in 2024 to US$ 600 million by 2031, with a CAGR of 6.9% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Rising pharmaceutical research and development: Increased investments in drug discovery and development are leading to a higher demand for cytotoxicity testing services to assess the safety and efficacy of new drugs. Stringent regulatory requirements: Regulatory agencies like the FDA and EMA are imposing stricter regulations on the safety of drugs and medical devices, mandating comprehensive cytotoxicity testing. Growing awareness of safety concerns: Increasing awareness about the potential toxicity of drugs, medical devices, and consumer products is driving the demand for cytotoxicity testing to ensure the safety of these products. Advances in technology: Technological advancements are leading to the development of more sensitive, specific, and high-throughput cytotoxicity testing methods, making them more efficient and cost-effective. Outsourcing trend: Pharmaceutical and biotechnology companies are increasingly outsourcing their cytotoxicity testing needs to specialized contract research organizations (CROs) due to expertise and cost considerations. Market Trends: Integration of automation and data analytics: Integrating cytotoxicity testing with automation and data analytics systems is enhancing efficiency, data traceability, and decision-making capabilities. Focus on high-throughput screening (HTS): HTS methods are increasingly being used to screen large libraries of compounds for potential cytotoxicity, leading to faster drug discovery and development. Development of 3D cell culture models: 3D cell culture models are becoming increasingly popular for cytotoxicity testing as they provide a more realistic environment for assessing the effects of substances on living cells. Focus on personalized medicine: Personalized cytotoxicity testing approaches are being developed to tailor testing protocols to individual patients based on their genetic makeup and other factors. Technological advancements: Advancements in areas like microfluidics and nanotechnology are leading to the development of new and improved cytotoxicity testing methods. Challenges and Opportunities: Stringent regulatory compliance requirements: Maintaining compliance with evolving regulatory requirements can be challenging for testing laboratories, requiring continuous investments in technology and expertise.

This report aims to provide a comprehensive study of the global market for Cytotoxicity Testing. Report Highlights:
(1) Global Cytotoxicity Testing market size (value), history data from 2020-2024, and forecast data from 2025 to 2031.

(2) Global Cytotoxicity Testing market competitive situation, revenue, and market share, from 2020 to 2024.

(3) China Cytotoxicity Testing market competitive situation, revenue, and market share, from 2020 to 2024.

(4) Global Cytotoxicity Testing segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Cytotoxicity Testing segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Cytotoxicity Testing industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    Elution Testing Method
    Agar Overlay Method
    Direct Contact Method
    MTT Assay Method
    Others

Market segment by Cell, covers
    Single-layer Cells
    Three-dimensional Cells
    Others

Market segment by Purpose, covers
    Toxicity Screening
    Toxicity Classification
    Toxicity Mechanism Research
    Others

Market segment by Application, can be divided into
    Medical Device
    Medical Accessories
    Others

Market segment by players, this report covers
    Intertek
    UL Solutions
    Eurofins Scientific
    SGS
    Creative Bioarray
    Nelson Labs
    SBH Sciences
    Pacific BioLabs
    NorthEast BioLab
    Charles River Laboratories
    INDIGO Biosciences
    Evercyte
    IONTOX
    Applied StemCell
    Xenometrix AG
    TÜV SÜD
    Medicilon
    Huatongwei